Tag Archives: Joint Ventures

December 18, 2020
FeaturedPress Release

A2i Therapeutics secures seed funding from FutuRx and its investors – Johnson & Johnson Innovation (JJDC, Inc.), Takeda Ventures, OrbiMed Partners, Leaps by Bayer and the Israeli Innovation Authority – to develop novel small molecule immuno-oncology agents. SAN FRANCISCO, CA and NESS ZIONA, Israel – December  18, 2020 – Atomwise, the leader in using artificial […]

Read Article
September 11, 2019
In The News

Mark Terry of BioSpace reports on Atomwise’s three new joint ventures.

Read Article
September 10, 2019
In The News

Connor Hale at FierceBiotech writes about Atomwise’s new joint ventures with SEngine Precision Medicine and OncoStatyx.

Read Article